Wednesday, 10 January 2018 ()
Pfizer, one of the world’s biggest pharmaceutical giants, is going to ditch their research efforts into new drugs to fight against Alzheimer’s disease and Parkinson’s disease. Pfizer justified the move by claiming it will help them "bring meaningful new therapies to market, and will bring the most value for shareholders and patients." "As a result of a recent comprehensive review, we have made the decision to...
| 0 shares | Share on FacebookShare on TwitterPost on RedditShare by |
Source: Wochit News - < > Embed
Pfizer Ends Research for New Alzheimer's, Parkinson's Drugs 00:45NEW YORK (Reuters) - Pfizer Inc (PFE.N) is abandoning research to find new drugs aimed at treating Alzheimer’s and Parkinson’s disease, the U.S. pharmaceutical company announced on Saturday. The company said it expects to eliminate 300 positions from the neuroscience discovery and early... |